Cargando…
Thymosin β4 Alleviates Autoimmune Dacryoadenitis via Suppressing Th17 Cell Response
PURPOSE: We investigated the therapeutic effect of recombinant thymosin β4 (rTβ4) on rabbit autoimmune dacryoadenitis, an animal model of SS dry eye, and explore its mechanisms. METHODS: Rabbits were treated topically with rTβ4 or PBS solution after disease onset for 28 days, and clinical scores wer...
Autores principales: | Zhao, Xiaoyu, Li, Na, Yang, Ning, Mi, Baoyue, Dang, Weiyu, Sun, Deming, Ma, Shanshan, Nian, Hong, Wei, Ruihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405860/ https://www.ncbi.nlm.nih.gov/pubmed/37531112 http://dx.doi.org/10.1167/iovs.64.11.3 |
Ejemplares similares
-
PPAR-α Agonist Fenofibrate Ameliorates Sjögren Syndrome–Like Dacryoadenitis by Modulating Th1/Th17 and Treg Cell Responses in NOD Mice
por: Guo, Xingyi, et al.
Publicado: (2022) -
Mesenchymal stem cells for treating autoimmune dacryoadenitis
por: Lu, Xiaoxiao, et al.
Publicado: (2017) -
Adipose-Derived Mesenchymal Stem Cells Reduce Lymphocytic Infiltration in a Rabbit Model of Induced Autoimmune Dacryoadenitis
por: Li, Xue, et al.
Publicado: (2018) -
MicroRNA expression profile of Lacrimal Glands in rabbit autoimmune dacryoadenitis model
por: Liu, Bo, et al.
Publicado: (2020) -
MSC-Derived Small Extracellular Vesicles Attenuate Autoimmune Dacryoadenitis by Promoting M2 Macrophage Polarization and Inducing Tregs via miR-100-5p
por: Li, Na, et al.
Publicado: (2022)